Insider activity update . . .
Selling at Memory, Immunicon, Eytech, Pharmion. A forced sale by CEO via margin call (of most of his position) at Advancis, very slightly offset by a directors buying a wee bit at the same time.
VC and insiders looking a bit better so far in this wave. Most of the bailing has come in companies that have actually performed well for their shareholders. Those that have not performed well, such as XCYT, not only face a diluting cash crunch, but seem to be handing out options like candy in an effort to keep employees from jumping ship. Vicious circle, that.
A small, timely sale at CGTK (before E2F1 decoy crashed).
Edit: Polaris bailing out of ALNY, which has been hot and liquid lately.
JP Morgan lightening in BTRX.
Automatic sales plans initiated and acted upon at several, including DVAX, CORT, GTOP.
CYTK, one VC lightens, another institution buys some; net 40,000 sold.
A sizeable sale in the summer at GTXI, with a smaller purchase a couple of months ago.
Much buying at INHX.
Cheers, Tuck |
